Inhibikase Therapeutics, Inc. - Common Stock (NQ:IKT)
  1.465
  
   
    +0.005 
    (+0.34%)
   
  
  
  Streaming Delayed Price
  Updated: 12:14 PM EDT, Oct 31, 2025
  Add to My Watchlist
 
 
 Headline News about Inhibikase Therapeutics, Inc. - Common Stock
    Inhibikase Posts Wider Loss in Q2
    
   August 14, 2025
   Via The Motley Fool
    
    
    
    
    
    
    
    
    
    
    
    
   
    Dow Jumps Over 100 Points; Helen Of Troy Posts Upbeat Q2 Results
    
    October 09, 2024
    
    
    
    
    
    
    
    
    
    
    
    
   
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
